Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney diseaseResearch in context

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney diseaseResearch in context

Background: Senescent cells, which can release factors that cause inflammation and dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with ageing and at etiological sites in multiple chronic diseases. Senolytics, including the combination of Dasatinib and Quercetin (D + Q)...

Full description

Bibliographic Details
Main Authors:	LaTonya J. Hickson, Larissa G.P. Langhi Prata, Shane A. Bobart, Tamara K. Evans, Nino Giorgadze, Shahrukh K. Hashmi, Sandra M. Herrmann, Michael D. Jensen, Qingyi Jia, Kyra L. Jordan, Todd A. Kellogg, Sundeep Khosla, Daniel M. Koerber, Anthony B. Lagnado, Donna K. Lawson, Nathan K. LeBrasseur, Lilach O. Lerman, Kathleen M. McDonald, Travis J. McKenzie, João F. Passos, Robert J. Pignolo, Tamar Pirtskhalava, Ishran M. Saadiq, Kalli K. Schaefer, Stephen C. Textor, Stella G. Victorelli, Tammie L. Volkman, Ailing Xue, Mark A. Wentworth, Erin O. Wissler Gerdes, Yi Zhu, Tamara Tchkonia, James L. Kirkland
Format:	Article
Language:	English
Published:	Elsevier 2019-09-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419305912

Similar Items

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
by: LaTonya J. Hickson, et al.
Published: (2020-02-01)

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot studyResearch in context
by: Jamie N. Justice, et al.
Published: (2019-02-01)

Targeting anxiety and senescence with senolytics
by: Raffaele, M., et al.
Published: (2022)

Identification of HSP90 inhibitors as a novel class of senolytics
by: Heike Fuhrmann-Stroissnigg, et al.
Published: (2017-09-01)

Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
by: Jasper Iske, et al.
Published: (2020-08-01)

A genetic modifier of symptom onset in Pompe diseaseResearch in context
by: Atze J. Bergsma, et al.
Published: (2019-05-01)

Evaluating the neuroprotective impact of senolytic drugs on human vision
by: Nevin W. El-Nimri, et al.
Published: (2020-12-01)

Senolytics and senostatics as adjuvant tumour therapy
by: Susan Short, et al.
Published: (2019-03-01)

Senolytics as drugs or fashionable dietary supplements
by: Małgorzata Starek, et al.
Published: (2021-05-01)

First evidence that senolytics are effective at decreasing senescent cells in humans
by: Georgina M. Ellison-Hughes
Published: (2020-06-01)

Biosynthetic homeostasis and resilience of the complement system in health and infectious diseaseResearch in context
by: Esther Willems, et al.
Published: (2019-07-01)

Identification and characterization of Cardiac Glycosides as senolytic compounds
by: Francisco Triana-Martínez, et al.
Published: (2019-10-01)

An Appraisal on the Value of Using Nutraceutical Based Senolytics and Senostatics in Aging
by: Amanpreet Kaur, et al.
Published: (2020-04-01)

Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin
by: Lea Beltzig, et al.
Published: (2021-07-01)

Senolytics for Cancer Therapy: Is All That Glitters Really Gold?
by: Valerie J. Carpenter, et al.
Published: (2021-02-01)

Effects of senolytic drugs on human mesenchymal stromal cells
by: Clara Grezella, et al.
Published: (2018-04-01)

A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
by: Leleesha Samaraweera, et al.
Published: (2017-05-01)

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery diseaseResearch in context
by: Michiel J. Bom, et al.
Published: (2019-01-01)

Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic diseaseResearch in context
by: Shijie Wang, et al.
Published: (2019-07-01)

The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice
by: Anuj K. Sharma, et al.
Published: (2020-05-01)

Seno-destructive smooth muscle cells in the ascending aorta of patients with bicuspid aortic valve diseaseResearch in context
by: Brittany Balint, et al.
Published: (2019-05-01)

Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells
by: Bernd Kaina, et al.
Published: (2020-09-01)

Senolytics (DQ) Mitigates Radiation Ulcers by Removing Senescent Cells
by: Huilan Wang, et al.
Published: (2020-02-01)

Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells.
by: HyunTae V Hwang, et al.
Published: (2018-01-01)

Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds
by: Francisco Triana-Martínez, et al.
Published: (2020-09-01)

Effect of Senolytic to alleviating Osteoporosis in Mice induced by Retinoic Acid
by: Liu Jia, et al.
Published: (2020-01-01)

Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer
by: Alimonti, A., et al.
Published: (2022)

Cellular Senescence: A Translational Perspective
by: James L. Kirkland, et al.
Published: (2017-07-01)

Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's diseaseResearch in context
by: Petar Podlesniy, et al.
Published: (2019-10-01)

Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseResearch in context
by: Xiqun Chen, et al.
Published: (2018-11-01)

Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial diseaseResearch in context
by: Eliana Barriocanal-Casado, et al.
Published: (2019-04-01)

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular diseaseResearch in context
by: Marika Mokou, et al.
Published: (2019-03-01)

Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung diseaseResearch in context
by: Anna-Maria Hoffmann-Vold, et al.
Published: (2019-12-01)

Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging
by: Harikrishnan Thoppil, et al.
Published: (2020-01-01)

Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapyResearch in context
by: Uxía Nogueira-Recalde, et al.
Published: (2019-07-01)

Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products
by: Oscar Salvador Barrera-Vázquez, et al.
Published: (2021-03-01)

The Notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary diseaseResearch in context
by: Carolina Ballester-López, et al.
Published: (2019-05-01)

Targeting senescent cells enhances adipogenesis and metabolic function in old age
by: Ming Xu, et al.
Published: (2015-12-01)

Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney diseaseResearch in context
by: Shaoqun Shu, et al.
Published: (2018-11-01)

A renal-cerebral-peripheral sympathetic reflex mediates insulin resistance in chronic kidney diseaseResearch in context
by: Wei Cao, et al.
Published: (2018-11-01)